Moolec Science (MLEC) Competitors

$7.77 0.00 (0.00%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$7.75 -0.02 (-0.26%)

As of 05/22/2026 04:04 PM Eastern

MLEC vs. ADGM, TOP, DFNS, TBMC, and MDRR

Should you buy Moolec Science stock or one of its competitors? MarketBeat compares Moolec Science with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Moolec Science include Adagio Medical (ADGM), TOP Financial Group (TOP), Nukkleus (DFNS), Trailblazer Merger Corporation I (TBMC), and Medalist Diversified REIT (MDRR). These companies are all part of the "trading" industry.

How does Moolec Science compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Moolec Science's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-382.50%	-64.98%
Moolec Science	N/A	N/A	N/A

In the previous week, Adagio Medical had 2 more articles in the media than Moolec Science. MarketBeat recorded 2 mentions for Adagio Medical and 0 mentions for Moolec Science. Adagio Medical's average media sentiment score of 0.45 beat Moolec Science's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Adagio Medical	Neutral
Moolec Science	Neutral

Adagio Medical currently has a consensus price target of $3.50, indicating a potential upside of 316.17%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Adagio Medical is more favorable than Moolec Science.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Adagio Medical has a beta of -0.14, suggesting that its stock price is 114% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 5.2% of Adagio Medical shares are held by company insiders. Comparatively, 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Adagio Medical has higher earnings, but lower revenue than Moolec Science. Adagio Medical is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	31.13	-$25.08M	-$1.53	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Summary

Adagio Medical beats Moolec Science on 9 of the 15 factors compared between the two stocks.

How does Moolec Science compare to TOP Financial Group?

TOP Financial Group (NASDAQ:TOP) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

TOP Financial Group has higher earnings, but lower revenue than Moolec Science.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TOP Financial Group	$3.33M	8.01	-$5.97M	N/A	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

TOP Financial Group has a beta of -0.95, meaning that its stock price is 195% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

0.3% of TOP Financial Group shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 85.6% of TOP Financial Group shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
TOP Financial Group	N/A	N/A	N/A
Moolec Science	N/A	N/A	N/A

In the previous week, TOP Financial Group had 6 more articles in the media than Moolec Science. MarketBeat recorded 6 mentions for TOP Financial Group and 0 mentions for Moolec Science. TOP Financial Group's average media sentiment score of 0.09 beat Moolec Science's score of 0.00 indicating that TOP Financial Group is being referred to more favorably in the media.

Company	Overall Sentiment
TOP Financial Group	Neutral
Moolec Science	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TOP Financial Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

TOP Financial Group beats Moolec Science on 7 of the 9 factors compared between the two stocks.

How does Moolec Science compare to Nukkleus?

Nukkleus (NASDAQ:DFNS) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Nukkleus has higher earnings, but lower revenue than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	2.36	$78.55M	$16.39	0.02
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Nukkleus has a beta of -5.98, meaning that its stock price is 698% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Moolec Science's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
Moolec Science	N/A	N/A	N/A

In the previous week, Nukkleus had 1 more articles in the media than Moolec Science. MarketBeat recorded 1 mentions for Nukkleus and 0 mentions for Moolec Science. Nukkleus' average media sentiment score of 1.08 beat Moolec Science's score of 0.00 indicating that Nukkleus is being referred to more favorably in the media.

Company	Overall Sentiment
Nukkleus	Positive
Moolec Science	Neutral

12.5% of Nukkleus shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 7.9% of Nukkleus shares are held by company insiders. Comparatively, 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nukkleus beats Moolec Science on 8 of the 13 factors compared between the two stocks.

How does Moolec Science compare to Trailblazer Merger Corporation I?

Moolec Science (NASDAQ:MLEC) and Trailblazer Merger Corporation I (NASDAQ:TBMC) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Trailblazer Merger Corporation I	N/A	N/A	-37.04%

Moolec Science has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, Trailblazer Merger Corporation I has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

In the previous week, Moolec Science's average media sentiment score of 0.00 equaled Trailblazer Merger Corporation I'saverage media sentiment score.

Company	Overall Sentiment
Moolec Science	Neutral
Trailblazer Merger Corporation I	Neutral

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 77.1% of Trailblazer Merger Corporation I shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 86.4% of Trailblazer Merger Corporation I shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Trailblazer Merger Corporation I	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Trailblazer Merger Corporation I has lower revenue, but higher earnings than Moolec Science.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Trailblazer Merger Corporation I	N/A	N/A	-$8.29M	N/A	N/A

Summary

Trailblazer Merger Corporation I beats Moolec Science on 4 of the 7 factors compared between the two stocks.

How does Moolec Science compare to Medalist Diversified REIT?

Moolec Science (NASDAQ:MLEC) and Medalist Diversified REIT (NASDAQ:MDRR) are both small-cap trading companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Medalist Diversified REIT has lower revenue, but higher earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Medalist Diversified REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Medalist Diversified REIT	$10.40M	1.60	-$2.39M	$3.75	2.72

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 17.4% of Medalist Diversified REIT shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by insiders. Comparatively, 43.8% of Medalist Diversified REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Medalist Diversified REIT has a net margin of 74.73% compared to Moolec Science's net margin of 0.00%. Moolec Science's return on equity of 0.00% beat Medalist Diversified REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Medalist Diversified REIT	74.73%	-16.90%	-6.11%

In the previous week, Medalist Diversified REIT had 5 more articles in the media than Moolec Science. MarketBeat recorded 5 mentions for Medalist Diversified REIT and 0 mentions for Moolec Science. Medalist Diversified REIT's average media sentiment score of 1.00 beat Moolec Science's score of 0.00 indicating that Medalist Diversified REIT is being referred to more favorably in the news media.

Company	Overall Sentiment
Moolec Science	Neutral
Medalist Diversified REIT	Positive

Moolec Science has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market. Comparatively, Medalist Diversified REIT has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Medalist Diversified REIT	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Medalist Diversified REIT beats Moolec Science on 11 of the 14 factors compared between the two stocks.

Get Moolec Science News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLEC vs. The Competition

Export

Metric	Moolec Science	AGRI OPERATIONS Industry	Staples Sector	NASDAQ Exchange
Market Cap	$5.64M	$3.17B	$16.25B	$12.34B
Dividend Yield	N/A	2.78%	3.51%	5.28%
P/E Ratio	-0.24	41.90	25.72	25.66
Price / Sales	0.02	3.60	47.48	86.31
Price / Cash	N/A	9.53	16.52	56.67
Price / Book	-0.03	4.52	5.27	7.14
Net Income	-$111.46M	-$6.23M	$674.03M	$335.98M
7 Day Performance	3.60%	0.69%	1.38%	4.11%
1 Month Performance	6.88%	-7.76%	-1.67%	2.52%
1 Year Performance	-94.30%	-15.47%	-12.21%	35.04%

Moolec Science Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLEC Moolec Science	N/A	$7.77 flat	N/A	-94.3%	$5.64M	$333.61M	N/A	4	Upcoming Earnings Gap Down
ADGM Adagio Medical	2.3919 of 5 stars	$0.97 +8.1%	$3.50 +259.3%	-29.3%	$21.68M	$600K	N/A	87
TOP TOP Financial Group	0.4295 of 5 stars	$0.80 -4.7%	N/A	-22.5%	$21.55M	$3.33M	N/A	11	Gap Down
DFNS Nukkleus	1.0554 of 5 stars	$0.49 +11.2%	N/A	-98.0%	$18.38M	$5.91M	0.03	12	Positive News Earnings Report Gap Down
TBMC Trailblazer Merger Corporation I	N/A	$7.33 flat	N/A	N/A	$17.96M	N/A	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MLEC) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Moolec Science (MLEC) Competitors

MLEC vs. ADGM, TOP, DFNS, TBMC, and MDRR

How does Moolec Science compare to Adagio Medical?

Summary

How does Moolec Science compare to TOP Financial Group?

Summary

How does Moolec Science compare to Nukkleus?

Summary

How does Moolec Science compare to Trailblazer Merger Corporation I?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Moolec Science (MLEC) Competitors

MLEC vs. ADGM, TOP, DFNS, TBMC, and MDRR

How does Moolec Science compare to Adagio Medical?

Is ADGM or MLEC more profitable?

Does the media favor ADGM or MLEC?

Do analysts recommend ADGM or MLEC?

Which has more risk & volatility, ADGM or MLEC?

Do institutionals & insiders believe in ADGM or MLEC?

Which has better valuation & earnings, ADGM or MLEC?

Summary

How does Moolec Science compare to TOP Financial Group?

Which has better earnings and valuation, TOP or MLEC?

Which has more risk & volatility, TOP or MLEC?

Do insiders and institutionals have more ownership in TOP or MLEC?

Is TOP or MLEC more profitable?

Does the media favor TOP or MLEC?

Do analysts prefer TOP or MLEC?

Summary

How does Moolec Science compare to Nukkleus?

Which has higher valuation & earnings, DFNS or MLEC?

Which has more risk & volatility, DFNS or MLEC?

Do analysts prefer DFNS or MLEC?

Is DFNS or MLEC more profitable?

Does the media favor DFNS or MLEC?

Do institutionals & insiders believe in DFNS or MLEC?

Summary

How does Moolec Science compare to Trailblazer Merger Corporation I?

Is MLEC or TBMC more profitable?

Which has more volatility and risk, MLEC or TBMC?

Does the media favor MLEC or TBMC?

Do institutionals and insiders hold more shares of MLEC or TBMC?

Do analysts rate MLEC or TBMC?

Which has stronger earnings & valuation, MLEC or TBMC?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Which has better valuation & earnings, MLEC or MDRR?

Do insiders and institutionals believe in MLEC or MDRR?

Is MLEC or MDRR more profitable?

Does the media refer more to MLEC or MDRR?

Which has more volatility & risk, MLEC or MDRR?

Do analysts recommend MLEC or MDRR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools